Tritylvalsartan
CAS: 195435-23-5
Rif. 3D-FT146985
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione |
Informazioni sul prodotto
- Triphenyl Valsartan
- Triphyl valsartan
- 3-Methyl-2-[pentanoyl-[[4-[2-(1-triphyltetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid
- Trityl valsartan
Tritylvalsartan is a prodrug that is metabolized to valsartan in the liver. It is an angiotensin receptor blocker (ARB) used for the treatment of chronic liver disease, heart failure and hypertension. Tritylvalsartan is a racemic mixture of two stereoisomers, cilexetil and benzonitrile, which are formed by the Suzuki coupling reaction with a chiral auxiliary. The drug has been shown to be effective in treating cardiovascular diseases with no serious side effects. Tritylvalsartan forms an ion-pair with chloride in the blood plasma and inhibits angiotensin II-induced constriction of blood vessels. It also acts as a competitive antagonist of the angiotensin receptors AT1 and AT2, blocking their activation by angiotensin II.